Stacy Salomonsen-Sautel1, Sung-Joon Min2, Joseph T Sakai2, Christian Thurstone3, Christian Hopfer2. 1. Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States. Electronic address: stacy.sautel@gmail.com. 2. Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States. 3. Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States; Denver Health and Hospital Authority, Denver, CO 80204, United States.
Abstract
BACKGROUND: Legal medical marijuana has been commercially available on a widespread basis in Colorado since mid-2009; however, there is a dearth of information about the impact of marijuana commercialization on impaired driving. This study examined if the proportions of drivers in a fatal motor vehicle crash who were marijuana-positive and alcohol-impaired, respectively, have changed in Colorado before and after mid-2009 and then compared changes in Colorado with 34 non-medical marijuana states (NMMS). METHODS: Thirty-six 6-month intervals (1994-2011) from the Fatality Analysis Reporting System were used to examine temporal changes in the proportions of drivers in a fatal motor vehicle crash who were alcohol-impaired (≥0.08 g/dl) and marijuana-positive, respectively. The pre-commercial marijuana time period in Colorado was defined as 1994-June 2009 while July 2009-2011 represented the post-commercialization period. RESULTS: In Colorado, since mid-2009 when medical marijuana became commercially available and prevalent, the trend became positive in the proportion of drivers in a fatal motor vehicle crash who were marijuana-positive (change in trend, 2.16 (0.45), p<0.0001); in contrast, no significant changes were seen in NMMS. For both Colorado and NMMS, no significant changes were seen in the proportion of drivers in a fatal motor vehicle crash who were alcohol-impaired. CONCLUSIONS: Prevention efforts and policy changes in Colorado are needed to address this concerning trend in marijuana-positive drivers. In addition, education on the risks of marijuana-positive driving needs to be implemented.
BACKGROUND:Legal medical marijuana has been commercially available on a widespread basis in Colorado since mid-2009; however, there is a dearth of information about the impact of marijuana commercialization on impaired driving. This study examined if the proportions of drivers in a fatal motor vehicle crash who were marijuana-positive and alcohol-impaired, respectively, have changed in Colorado before and after mid-2009 and then compared changes in Colorado with 34 non-medical marijuana states (NMMS). METHODS: Thirty-six 6-month intervals (1994-2011) from the Fatality Analysis Reporting System were used to examine temporal changes in the proportions of drivers in a fatal motor vehicle crash who were alcohol-impaired (≥0.08 g/dl) and marijuana-positive, respectively. The pre-commercial marijuana time period in Colorado was defined as 1994-June 2009 while July 2009-2011 represented the post-commercialization period. RESULTS: In Colorado, since mid-2009 when medical marijuana became commercially available and prevalent, the trend became positive in the proportion of drivers in a fatal motor vehicle crash who were marijuana-positive (change in trend, 2.16 (0.45), p<0.0001); in contrast, no significant changes were seen in NMMS. For both Colorado and NMMS, no significant changes were seen in the proportion of drivers in a fatal motor vehicle crash who were alcohol-impaired. CONCLUSIONS: Prevention efforts and policy changes in Colorado are needed to address this concerning trend in marijuana-positive drivers. In addition, education on the risks of marijuana-positive driving needs to be implemented.
Authors: Luke A Downey; Rebecca King; Katherine Papafotiou; Phillip Swann; Edward Ogden; Martin Boorman; Con Stough Journal: Accid Anal Prev Date: 2012-08-04
Authors: Wendy M Bosker; Kim P C Kuypers; Eef L Theunissen; Anke Surinx; Roos J Blankespoor; Gisela Skopp; Wayne K Jeffery; H Chip Walls; Cees J van Leeuwen; Johannes G Ramaekers Journal: Addiction Date: 2012-07-12 Impact factor: 6.526
Authors: Franjo Grotenhermen; Gero Leson; Günter Berghaus; Olaf H Drummer; Hans-Peter Krüger; Marie Longo; Herbert Moskowitz; Bud Perrine; Johannes G Ramaekers; Alison Smiley; Rob Tunbridge Journal: Addiction Date: 2007-10-04 Impact factor: 6.526
Authors: Carla J Berg; Carmen N Daniel; Milkie Vu; Jingjing Li; Kathleen Martin; Lana Le Journal: Subst Use Misuse Date: 2017-08-04 Impact factor: 2.164
Authors: John R Knight; Ladislav Csemy; Lon Sherritt; Olga Starostova; Shari Van Hook; Janine Bacic; Caroline Finlay; Jessica Tauber; Traci Brooks; Robert Kossack; John W Kulig; Judith Shaw; Sion Kim Harris Journal: J Stud Alcohol Drugs Date: 2018-07 Impact factor: 2.582
Authors: Samuel T Wilkinson; Stephanie Yarnell; Rajiv Radhakrishnan; Samuel A Ball; Deepak Cyril D'Souza Journal: Annu Rev Med Date: 2015-10-19 Impact factor: 13.739
Authors: Jonathan M Davis; Bruce Mendelson; Jay J Berkes; Katie Suleta; Karen F Corsi; Robert E Booth Journal: Am J Prev Med Date: 2015-09-16 Impact factor: 5.043